| 1 |
5-amino salicylic acid (5-asa) |
Mesalazine |
[2] D00097 D00097, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
| 2 |
5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
| 3 |
5-aminosalicylic acid(5-asa) and/or prednisone |
Aminosalicylic acid |
[3] D00162 D00162, D00377 D00377, D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
| 4 |
5-asa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [2] 96, 97 💬 |
| 5 |
5-asa (5-aminosalicylate) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
| 6 |
5-asa mmx |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
| 7 |
Mesalamine, 5-aminosalicylic acid [5-asa] |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
| 8 |
Mesalamine, 5-asa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
| 9 |
Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone |
Mesalazine |
[7] D00377 D00377, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
| 10 |
Other: 5-asa withdrawal |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
| 11 |
Other: pentasa (mesalamine/ 5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |